ALK-positive anaplastic large-cell lymphoma: strong T and B anti-tumour responses may cause hypocellular aspects of lymph nodes mimicking inflammatory lesions-Reference-Cited by-同舟云学术

ALK-positive anaplastic large-cell lymphoma: strong T and B anti-tumour responses may cause hypocellular aspects of lymph nodes mimicking inflammatory lesions

Published:2003-09-01 Issue:4 Volume:71 Page:243-249
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Borisch B.,Yerly S.,Cerato Ch.,Schwaller J.,Wacker P.,Ozsahin A. H.,Brousse N.,Hoessli D. C.

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1600-0609.2003.00144.x/fullpdf

Reference16 articles.

1. Fusion of a kinase gene, ALK, to a nucleolar protein gem, NPM, in non-Hodgkin's lymphoma;Morris;Science,1994

2. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features;Stein;Blood,2000

3. Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma;Pulford;Am J Pathol,1999

4. Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma;Pulford;Blood,2000

5. ALK+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma;Morris;Br J Hematol,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The sphingolipid-rich rafts of ALK+ lymphomas downregulate the Lyn-Cbp/PAG signalosome;European Journal of Haematology;2010-06

2. Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase–positive anaplastic large cell lymphoma with tumor dissemination and relapse risk;Blood;2010-04-22

3. Expression of ALK protein, mRNA and fusion transcripts in anaplastic large cell lymphoma;Experimental and Molecular Pathology;2009-04

4. PET/CT Examination in an Anaplastic Malignant Lymphoma With Extensive Reactive Involvement;Clinical Nuclear Medicine;2008-09

5. Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy;Medicinal Research Reviews;2008